FDA Adverse Event Malfunction Summary report: N

SUTURABLE DURAGEN DURAL REGEN MATRIX

MDR report key: 2211081 · Received August 5, 2011

Report

Report Number
1121308-2011-00029
Event Type
Malfunction
Date Received
August 5, 2011
Report Date
August 5, 2011
Manufacturer
INTEGRA, PLAINSBORO
Product Code
GXQ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TO DATE, THE DEVICE INVOLVED IN THE REPORTED INCIDENT HAS NOT BEEN REC'D FOR EVAL. AN INVESTIGATION HAS BEEN INITIATED BASED UPON THE REPORTED INFO.

Description of Event or Problem · 1

THERE WAS A REPORT OF A CEREBROSPINAL FLUID LEAKAGE WITH SUTURABLE DURAGEN IN THE POSTERIOR FOSSE AND SUPERNATANT AREAS 15 DAYS POST OPERATIVELY. THE SPECIFIC PRODUCT COULD NOT BE IDENTIFIED; HOWEVER, IT IS BELIEVED THAT IT COULD EITHER BE (DURS 2291-ITL OR DURS 3391-ITL) THE PT HAD TO RETURN TO THE HOSPITAL AS A RESULT OF THE LEAKAGE. IT WAS REPORTED THAT THIS WAS NOT RELATED TO A DRAINAGE ISSUE OR HYDROCEPHALUS CONSEQUENCES. THE SUTURABLE DURAGEN WAS USED FOLLOWING INTEGRA LIFESCIENCES GUIDELINES WITH MINIMUM SUTURE TENSION; NO SEALANT WAS USED WITH THE PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SUTURABLE DURAGEN DURAL REGEN MATRIX NA GXQ INTEGRA, PLAINSBORO

Patients

Seq Age Sex Outcome Treatment
1